Small-cap stocks continue low; BXC, VQ, and MHS lead gainers
Small-cap stocks extended morning losses into the midday time frame, as another batch of dour economic numbers quickly refocused attention from the U.S. elections back onto the recession. Today's small-cap gainers were BlueLinx Holdings (NYSE:BXC), Venoco, Inc. (NYSE:VQ) and Medco Health (NYSE:MHS).
[ More ยป ]
Other Market Watch highlights included: • Commodities (a big plus for the market on Tuesday) were struggling today. Crude oil prices were off 7% after soaring 10% Tuesday. • The best performers are homebuilders, health care services, managed health care and office supplies. • Forest products, tire and rubber stocks, health care facilities, coal, Internet retail and broadcast TV companies are the worst performers. • The jobs issue is now on the front burner ahead of Friday’s big employment report, which is expected to show a nasty decline. • Drug, technology and financial shares paced today’s decline, fueled by worries that a recession in the U.S., global slowdown would dampen corporate profitability and deepen jobs losses. Small Cap Gainers: • BlueLinx Holdings up 20% after appointing George Judd CEO today. See (NYSE:BXC). • Independent energy company Venoco, Inc. up 16% on higher-than-average volume. See (NYSE:VQ). • Medco Health shares up 13% after seeing 38% rise in Q3 profit. See (NYSE:MHS). • Natural Gas Services Group announces a 43% increase in Diluted EPS for Q3; shares climb over 11%. See (NYSE:NGS). • Genco Shipping cancels agreement to acquire six drybulk newbuildings; shares up over 8%. See (NYSE:GNK). Small Cap Losers: • NeuStar reports Q3 results, downgraded to "buy" from "strong buy." Shares dive 20%. See (NYSE:NSR). • Ashford Hospitality Trust down 20% after naming interim CFO. See (NYSE:AHT). • Reports say Advance America, Cash Advance could take $42M hit if forced to close Ohio centers. Shares careen 15%. See (NYSE:AEA). • Fitch downgraded Colonial BancGroup's ratings last week; shares dive over 22% today. See (NYSE:CNB). • Simcere Pharmaceutical Group down 25% on heavier-than-average volume. See (NYSE:SCR) spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer
|
|